Pages that link to "Q36678832"
Jump to navigation
Jump to search
The following pages link to Multiple sclerosis and the hygiene hypothesis (Q36678832):
Displaying 50 items.
- Helminth infections and host immune regulation (Q26829956) (← links)
- Potential treatment of inflammatory bowel disease: a review of helminths therapy (Q27027621) (← links)
- Helminthic therapy: improving mucosal barrier function (Q28263272) (← links)
- Schistosome infection intensity is inversely related to auto-reactive antibody levels (Q28478071) (← links)
- Helminth/Parasite Treatment of Multiple Sclerosis (Q29039518) (← links)
- The impact of parasite infections on the course of multiple sclerosis (Q29302265) (← links)
- Trichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosis (Q30658854) (← links)
- Environmental factors influencing multiple sclerosis in Latin America (Q33803071) (← links)
- Environmental factors in early childhood are associated with multiple sclerosis: a case-control study (Q34041828) (← links)
- Environmental risk factors in multiple sclerosis (Q34100847) (← links)
- Probiotic helminth administration in relapsing–remitting multiple sclerosis: a phase 1 study (Q34168414) (← links)
- Hygiene Hypothesis and Autoimmune Diseases (Q34233260) (← links)
- Chronic helminth infection does not exacerbate Mycobacterium tuberculosis infection (Q34535318) (← links)
- Are the Prevalence and Incidence of Multiple Sclerosis Changing? (Q34985158) (← links)
- Role of pathogens in multiple sclerosis (Q35206805) (← links)
- Parasitic Helminth Cystatin Inhibits DSS-Induced Intestinal Inflammation Via IL-10 F4/80 Macrophage Recruitment (Q35535481) (← links)
- Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β. (Q35659179) (← links)
- Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America (Q35907969) (← links)
- Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients? (Q36186863) (← links)
- Helminths, hygiene hypothesis and type 2 diabetes (Q36214734) (← links)
- Absence of Multiple Sclerosis and Demyelinating Diseases among Lacandonians, a Pure Amerindian Ethnic Group in Mexico (Q36220907) (← links)
- Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial (Q36924572) (← links)
- Vitamin D and multiple sclerosis: an update (Q37015229) (← links)
- Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. (Q37047749) (← links)
- Worms and the treatment of inflammatory bowel disease: are molecules the answer? (Q37176060) (← links)
- Helminths and the IBD hygiene hypothesis (Q37235236) (← links)
- A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. (Q37435137) (← links)
- Regulation of type 1 diabetes, tuberculosis, and asthma by parasites (Q37618585) (← links)
- Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis (Q37813014) (← links)
- Multiple sclerosis in Caucasians and Latino Americans (Q37923513) (← links)
- The impact of environmental infections (parasites) on MS activity (Q37943294) (← links)
- Regulatory T cells in infection (Q37961175) (← links)
- Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis. (Q38066249) (← links)
- The hygiene theory harnessing helminths and their ova to treat autoimmunity (Q38074593) (← links)
- Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis. (Q38199165) (← links)
- Helminth therapy or elimination: epidemiological, immunological, and clinical considerations (Q38224936) (← links)
- Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection (Q38517180) (← links)
- Brugia malayi soluble and excretory-secretory proteins attenuate development of streptozotocin-induced type 1 diabetes in mice (Q38872408) (← links)
- Breaking down the gut microbiome composition in multiple sclerosis (Q39036835) (← links)
- Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance (Q39406411) (← links)
- Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect (Q41474442) (← links)
- Immunoregulation by Taenia crassiceps and its antigens (Q41480089) (← links)
- Production and analysis of immunomodulatory excretory-secretory products from the mouse gastrointestinal nematode Heligmosomoides polygyrus bakeri (Q41674068) (← links)
- Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no. (Q42241081) (← links)
- Soil-transmitted helminth prevalence and infection intensity among geographically and economically distinct Shuar communities in the Ecuadorian Amazon (Q43318070) (← links)
- Application of dendritic cells stimulated with Trichinella spiralis excretory-secretory antigens alleviates experimental autoimmune encephalomyelitis. (Q45340759) (← links)
- Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms. (Q45842759) (← links)
- Vitamin A and systemic inflammation as protective factors in multiple sclerosis (Q46105413) (← links)
- Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011-2015. (Q47595237) (← links)
- Is the hygiene hypothesis relevant for the risk of multiple sclerosis? (Q47600994) (← links)